A Message From the CEO
Accomplishing Things That Matter
Dear Colleagues and Friends,
As you peruse this Annual Report, I think you’ll be struck by a number of things. One of them, perhaps the most important, is that the Foundation accomplishes things that matter! It’s not just one or two programs, but a spectrum from professional education, to public education, to public service, to best-in-the world quality of care research. And the impact is sustained.
More recently, the Foundation was essential to the development of the IRIS Clinical Data Registry. It required an investment of over $10 million. And it demanded of both the Academy and of the Foundation Board of Trustees a sense of vision and of commitment to build an infrastructure and the analytic technology necessary to succeed. The result is a transformative tool with impacts on federal policy, population-based research, quality of care and professional analytics.
Next year we will witness the opening of the world’s only comprehensive, publicly-accessible Museum of the Eye. The lion’s share of the funding comes from our colleagues and Academy members—most notably, Drs. Stan Truhlsen and Mike Marmor. It’s a reflection of our own professional commitment to our heritage and to public education.
Finally, as you read this report, note the generosity of your friends and colleagues. Please thank them on behalf of us all.
Best regards,
David W. Parke II, MD
Chief Executive Officer
American Academy of Ophthalmology
The American Academy of Ophthalmology Foundation Advisory Board
The American Academy of Ophthalmology Foundation
The American Academy of Ophthalmology Foundation leadership is proud to support the Academy’s educational, quality of care and service programs. Through their generosity and guidance, these dedicated leaders drive our important work to advance eye health worldwide.
Gregory L. Skuta, MD
Chair
President and CEO, Dean McGee Eye Institute
Oklahoma City, Okla.
Tony McClellan
President
Chairman, Brookend Enterprises Management Services, Ltd.
Herefordshire, United Kingdom
F. Michael Ball
Chairman-designate, Alcon, Inc.
Fort Worth, Texas
George B. Bartley, MD
CEO, American Board of Ophthalmology
Rochester, Minn.
Thomas W. Burns
President and CEO, Glaukos Corp.
San Clemente, Calif.
Thomas G. Frinzi
Worldwide President, Surgical, Johnson & Johnson Vision
Santa Ana, Calif.
David D. Goodwin
Trustee, Knights Templar Eye Foundation, Inc.
Vestal, N.Y.
H. Dunbar Hoskins Jr., MD
Executive Vice President Emeritus
American Academy of Ophthalmology
Belvedere, Calif.
James V. Mazzo
Global President, Ophthalmic Devices,
Carl Zeiss Meditec, Inc.
Dublin, Calif.
Christie L. Morse, MD
Ophthalmologist, Concord Eye Care
Concord, N.H.
Charles R. Munnerlyn, PhD
Co-founder and Retired CEO, VISX, Inc.
San Jose, Calif.
David E. I. Pyott, CBE, MD (Hon.)
Former Chairman and CEO, Allergan, Inc.
Irvine, Calif.
Brent L. Saunders
CEO and President, Allergan plc
Madison, N.J.
Peter J. Whitted, MD, JD
Ophthalmologist, Midwest Eye Care
Omaha, Neb.
- - - - - - - - - -
David W. Parke II, MD
CEO
American Academy of Ophthalmology
San Francisco, Calif.
Tina McGovern
Executive Director
American Academy of Ophthalmology Foundation
San Francisco, Calif.